Activation of functional α7-containing nAChRs in hippocampal CA1 pyramidal neurons by physiological levels of choline in the presence of PNU-120596

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Kalappa, Bopanna I ^a   Gusev, Alexander G ^a   Uteshev, Victor V ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; CHOLINE; N (5 CHLORO 2,4 DIMETHOXYPHENYL) N (5 METHYL 3 ISOXAZOLYL)UREA; NICOTINIC RECEPTOR BLOCKING AGENT; PNU 120596; UNCLASSIFIED DRUG; 1 (5 CHLORO 2,4 DIMETHOXYPHENYL) 3 (5 METHYLISOXAZOL 3 YL)UREA; 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA; CARBANILAMIDE DERIVATIVE; ISOXAZOLE DERIVATIVE; NICOTINIC RECEPTOR; NOOTROPIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPACITANCE BLOOD VESSEL; CELL STRUCTURE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HIPPOCAMPUS; INTERNEURON; LATENT PERIOD; MALE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE POTENTIAL; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; ACTION POTENTIAL; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HIPPOCAMPAL CA1 REGION; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ACTION POTENTIALS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CHOLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; ISOXAZOLES; MALE; NOOTROPIC AGENTS; PATCH-CLAMP TECHNIQUES; PHENYLUREA COMPOUNDS; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 78649735548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013964     Document Type: Article

References (71)

1. Kandel ER (2009) The biology of memory: a forty-year perspective. J Neurosci 29: 12748-12756.
2. Jiang Z, Belforte JE, Lu Y, Yabe Y, Pickel J, et al. (2010) eIF2alpha Phosphorylation-dependent translation in CA1 pyramidal cells impairs hippo-campal memory consolidation without affecting general translation. J Neurosci 30: 2582-2594.
3. Chen C, Tonegawa S (1997) Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain. Annu Rev Neurosci 20: 157-184.
4. Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87: 1327-1338.
5. Kim HJ, Chae SC, Lee DK, Chromy B, Lee SC, et al. (2003) Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein. FASEB J 17: 118-120.
6. Bobinski M, de Leon MJ, Tarnawski M, Wegiel J, Reisberg B, et al. (1998) Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res 805: 267-269.
7. Kirino T (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239: 57-69.
8. Pulsinelli WA, Brierley JB, Plum F (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11: 491-498.
9. Shimohama S, Kihara T (2001) Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity. Biol Psychiatry 49: 233-239.
10. Disterhoft JF, Oh MM (2007) Alterations in intrinsic neuronal excitability during normal aging. Aging Cell 6: 327-336.
11. Kaczorowski CC, Disterhoft JF (2009) Memory deficits are associated with impaired ability to modulate neuronal excitability in middle-aged mice. Learn Mem 16: 362-366.
12. Son JH, Winzer-Serhan UH (2008) Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs in rat hippocampal GABAergic interneurons. J Comp Neurol 511: 286-299.
13. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89: 73-120.
14. Egea J, Rosa AO, Sobrado M, Gandia L, Lopez MG, et al. (2007) Neuroprotection afforded by nicotine against oxygen and glucose deprivation in hippocampal slices is lost in alpha7 nicotinic receptor knockout mice. Neuroscience 145: 866-872.
15. Guseva MV, Hopkins DM, Scheff SW, Pauly JR (2008) Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury. J Neurotrauma 25: 975-983.
16. Shimohama S, Greenwald DL, Shafron DH, Akaike A, Maeda T, et al. (1998) Nicotinic a7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res 779: 359-363.
17. Verbois SL, Scheff SW, Pauly JR (2003) Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury. Neurophar-macology 44: 224-233.
18. Buccafusco JJ, (2004) Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS. MolInterv 4: 285-295.
19. Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM (2005) Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance. Trends Pharmacol Sci 26: 352-360.
20. Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 40: 211-216.
21. Shimohama S, (2009) Nicotinic receptor-mediated neuroprotection in neurode-generative disease models. Biol Pharm Bull 32: 332-336.
22. Li Y, Papke RL, He YJ, Millard B, Meyer EM (1999) Characterization of the neuroprotective and toxic effects of a7 nicotinic receptor activation in PC12 cells. Brain Res 81: 218-225.
23. Kem WR, (2000) The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res 113: 169-181.
24. Meyer EM, Tay ET, Papke RL, Meyers C, Huang G, et al. (1997) Effects of 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) on rat nicotinic receptors and memory-related behaviors. Brain Res 768: 49-56.
25. Buccafusco JJ, Terry AV, Jr., Decker MW, Gopalakrishnan M, (2007) Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochem Pharmacol 74: 1202-1211.
26. Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, et al. (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28: 542-551.
27. Ren K, Thinschmidt J, Liu J, Ai L, Papke RL, et al. (2007) alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation. Neuroscience 145: 314-322.
28. Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD, (2010) Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 16: 323-343.
29. Leiser SC, Bowlby MR, Comery TA, Dunlop J, (2009) A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 122: 302-311.
30. Olincy A, Stevens KE, (2007) Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol 74: 1192-1201.
31. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, et al. (2010) Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry 51: 535-549.
32. Mielke JG, Mealing GA (2009) Cellular distribution of the nicotinic acetylcholine receptor alpha7 subunit in rat hippocampus. Neurosci Res 65: 296-306.
33. Jones S, Yakel JL, (1997) Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504(Pt 3): 603-610.
34. McQuiston AR, Madison DV, (1999) Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 19: 2887-2896.
35. Frazier CJ, Rollins YD, Breese CR, Leonard S, Freedman R, et al. (1998) Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci 18: 1187-1195.
36. Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV, (1998) Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18: 8228-8235.
37. Grybko M, Sharma G, Vijayaraghavan S, (2010) Functional distribution of nicotinic receptors in CA3 region of the hippocampus. J Mol Neurosci 40: 114-120.
38. Ji D, Lape R, Dani JA (2001) Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31: 131-141.
39. Faghih R, Gfesser GA, Gopalakrishnan M, (2007) Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Recent Patents CNS Drug Discov 2: 99-106.
40. Hurst RS, Hajos M, Raggenbass M, Wall TM, Higdon NR, et al. (2005) A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. J Neurosci 25: 4396-4405.
41. Lopez-Hernandez GY, Thinschmidt JS, Morain P, Trocme-Thibierge C, Kem WR, et al. (2009) Positive modulation of alpha7 nAChR responses in rat hippocampal interneurons to full agonists and the alpha7-selective partial agonists, 4OH-GTS-21 and S 24795. Neuropharmacology.
42. Roncarati R, Seredenina T, Jow B, Jow F, Papini S, et al. (2008) Functional properties of alpha7 nicotinic acetylcholine receptors co-expressed with RIC-3 in a stable recombinant CHO-K1 cell line. Assay Drug Dev Technol 6: 181-193.
43. Gusev AG, Uteshev VV, (2009) Physiological concentrations of choline activate native {alpha}7-containing nicotinic acetylcholine receptors in the presence of PNU-120596. J Pharmacol Exp Ther.
44. Young GT, Zwart R, Walker AS, Sher E, Millar NS, (2008) Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site. Proc Natl Acad Sci USA 105: 14686-14691.
45. Gronlien JH, Hakerud M, Ween H, Thorin-Hagene K, Briggs CA, et al. (2007) Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes. Mol Pharmacol 72: 715-724.
46. Jope RS, Gu X, (1991) Seizures increase acetylcholine and choline concentrations in rat brain regions. Neurochem Res 16: 1219-1226.
47. Scremin OU, Jenden DJ, (1991) Time-dependent changes in cerebral choline and acetylcholine induced by transient global ischemia in rats. Stroke 22: 643-647.
48. Bertrand N, Ishii H, Spatz M, (1996) Cerebral ischemia in young and adult gerbils: effects on cholinergic metabolism. Neurochem Int 28: 293-297.
49. Grimm D, Kern A, Rittner K, Kleinschmidt JA, (1998) Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 9: 2745-2760.
50. Zapata A, Capdevila JL, Trullas R, (1998) Region-specific and calcium-dependent increase in dialysate choline levels by NMDA. J Neurosci 18: 3597-3605.
51. Rao AM, Hatcher JF, Dempsey RJ, (2000) Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection. J Neurochem 75: 2528-2535.
52. Sarter M, Parikh V, (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6: 48-56.
53. Parikh V, Sarter M, (2006) Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J Neurochem 97: 488-503.
54. Mike A, Castro NG, Albuquerque EX, (2000) Choline and acetylcholine have similar kinetic properties of activation and desensitization on the alpha7 nicotinic receptors in rat hippocampal neurons. Brain Res 882: 155-168.
55. Barron SC, McLaughlin JT, See JA, Richards VL, Rosenberg RL, (2009) The allosteric modulator of {alpha}7 nicotinic receptors, PNU-120596, causes conformational changes in the extracellular ligand binding domain similar to acetylcholine. Mol Pharmacol.
56. Uteshev VV, Meyer EM, Papke RL, (2003) Regulation of neuronal function by choline and 4OH-GTS-21 through alpha 7 nicotinic receptors. Journal of Neurophysiology 89: 1797-1806.
57. Meyer E, Kuryatov A, Gerzanich V, Lindstrom J, Papke RL, (1998) Analysis of 40H-GTS-21 Selectivity and Activity at Human and Rat a7 Nicotinic Receptors. J Pharmacol Exp Ther 287: 918-925.
58. Arendash GW, Sanberg PR, Sengstock GJ, (1995) Nicotine enhances the learning and memory of aged rats. Pharmacol Biochem Behav 52: 517-523.
59. Alkondon M, Reinhardt S, Lobron C, Hermsen B, Maelicke A, et al. (1994) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole cell currents and identification of receptor subunits by in situ hybridization. J Phamacol Exp Ther 271: 494-506.
60. Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX, (1997) Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 9: 2734-2742.
61. Papke RL, Porter Papke JK, (2002) Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. Br J Pharmacol 137: 49-61.
62. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, et al. (1997) Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 42: 159-163.
63. Akaike A, Tamura Y, Yokota T, Shimohama S, Kimura J, (1994) Nicotine-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 644: 181-187.
64. Disterhoft JF, Oh MM, (2006) Learning, aging and intrinsic neuronal plasticity. Trends Neurosci 29: 587-599.
65. Buccafusco JJ, Beach JW, Terry AV, Jr., Doad GS, Sood A, et al. (2004) Novel analogs of choline as potential neuroprotective agents. J Alzheimers Dis 6: S85-S92.
66. Uteshev VV, Meyer EM, Papke RL, (2002) Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors. Brain Research 948: 33-46.
67. Castro NG, Albuquerque EX (1995) a-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability. Biophys J 68: 516-524.
68. Uteshev VV, (2010) Evaluation of Ca2+ permeability of nicotinic acetylcholine receptors in hypothalamic histaminergic neurons. Acta Biochim Biophys Sin (Shanghai) 42: 8-20.
69. Ji D, Dani JA, (2000) Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurphysiol 83: 2682-2690.
70. Albuquerque EX, Alkondon M, Pereira EF, Castro NG, Schrattenholz A, et al. (1997) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136.
71. Adams CE, Broide RS, Chen Y, Winzer-Serhan UH, Henderson TA, et al. (2002) Development of the alpha7 nicotinic cholinergic receptor in rat hippocampal formation. Brain Res Dev Brain Res 139: 175-187.